AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS)

Clinical trials for AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.

Never miss a new study

Get alerted when new AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS) trials appear

Sign up with your email to follow new studies for AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for older, frailer leukemia patients in major drug trial

Disease control Ongoing

This study is testing whether adding a new drug called AG-120 (ivosidenib) to standard chemotherapy (azacitidine) works better than the standard chemo alone for adults with a specific type of newly diagnosed acute myeloid leukemia (AML). It is for patients aged 18 and older who a…

Matched conditions: AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS)

Phase: PHASE3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS)

Get alerted when new AML ARISING FROM MYELODYSPLASTIC SYNDROME (MDS) trials appear

New hope for older, frailer leukemia patients in major drug trial